{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:27:28Z","timestamp":1775896048642,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.msard.2020.102685","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T18:01:52Z","timestamp":1607536912000},"page":"102685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Frequency of comorbidities in Neuromyelitis Optica spectrum disorder"],"prefix":"10.1016","volume":"48","author":[{"given":"Mahdi","family":"Barzegar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Mirmosayyeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasim","family":"Nehzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Vaheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102685_bib0001","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2017.11.022","article-title":"Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica","volume":"384","author":"Ajmera","year":"2018","journal-title":"Journal of the neurological sciences"},{"issue":"3","key":"10.1016\/j.msard.2020.102685_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study","volume":"24","author":"Asgari","year":"2018","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.msard.2020.102685_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1735-1995.202142","article-title":"Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study","volume":"22","author":"Ashtari","year":"2017","journal-title":"Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences"},{"issue":"11","key":"10.1016\/j.msard.2020.102685_bib0004","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/jnnp-2017-317202","article-title":"Low body mass index can be associated with the risk and poor outcomes of neuromyelitis optica with aquaporin-4 immunoglobulin G in women","volume":"89","author":"Baek","year":"2018","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.msard.2020.102685_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.msard.2018.04.009","article-title":"Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran","volume":"22","author":"Barzegar","year":"2018","journal-title":"Multiple sclerosis and related disorders"},{"key":"10.1016\/j.msard.2020.102685_bib0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.msard.2019.04.008","article-title":"Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls","volume":"32","author":"Barzegar","year":"2019","journal-title":"Multiple sclerosis and related disorders"},{"issue":"4","key":"10.1016\/j.msard.2020.102685_bib0007","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: Patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurology-Neuroimmunology Neuroinflammation"},{"issue":"6","key":"10.1016\/j.msard.2020.102685_bib0008","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000286","article-title":"Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder","volume":"3","author":"Chavarro","year":"2016","journal-title":"Neurology-Neuroimmunology Neuroinflammation"},{"issue":"9","key":"10.1016\/j.msard.2020.102685_bib0009","doi-asserted-by":"crossref","first-page":"e01350","DOI":"10.1002\/brb3.1350","article-title":"Blood pressure and body fat percent in women with NMOSD","volume":"9","author":"Chen","year":"2019","journal-title":"Brain and Behavior"},{"issue":"10","key":"10.1016\/j.msard.2020.102685_bib0010","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1526-4610.2009.01427.x","article-title":"Frequency of chronic headaches in Japanese patients with multiple sclerosis: with special reference to opticospinal and common forms of multiple sclerosis","volume":"49","author":"Doi","year":"2009","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"5","key":"10.1016\/j.msard.2020.102685_bib0011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3343\/alm.2012.32.5.331","article-title":"Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder","volume":"32","author":"E-s","year":"2012","journal-title":"Annals of laboratory medicine"},{"issue":"3","key":"10.1016\/j.msard.2020.102685_bib0012","first-page":"93","article-title":"Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder","volume":"18","author":"Eskandarieh","year":"2019","journal-title":"Iranian Journal of Neurology"},{"key":"10.1016\/j.msard.2020.102685_bib0013","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Multiple sclerosis and related disorders"},{"issue":"1","key":"10.1016\/j.msard.2020.102685_bib0014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clineuro.2011.07.020","article-title":"Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis","volume":"114","author":"Etemadifar","year":"2012","journal-title":"Clinical neurology and neurosurgery"},{"issue":"7","key":"10.1016\/j.msard.2020.102685_bib0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","article-title":"The pre-therapeutic classification of co-morbidity in chronic disease","volume":"23","author":"Feinstein","year":"1970","journal-title":"Journal of chronic diseases"},{"key":"10.1016\/j.msard.2020.102685_bib0016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msard.2017.11.002","article-title":"Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina","volume":"19","author":"Fern\u00e1ndez","year":"2018","journal-title":"Multiple sclerosis and related disorders"},{"key":"10.1016\/j.msard.2020.102685_bib0017","series-title":"Immunobiology: The Immune System in Health and Disease","article-title":"Autoimmune responses are directed against self antigens","author":"Janeway Jr","year":"2001"},{"issue":"11","key":"10.1016\/j.msard.2020.102685_bib0018","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102685_bib0019","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"Journal of Experimental Medicine"},{"issue":"9451","key":"10.1016\/j.msard.2020.102685_bib0020","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.msard.2020.102685_bib0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2020.102685_bib0022","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1474-4422(10)70135-6","article-title":"Emerging effects of comorbidities on multiple sclerosis","volume":"9","author":"Marrie","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"15","key":"10.1016\/j.msard.2020.102685_bib0023","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1212\/WNL.0000000000002474","article-title":"Recommendations for observational studies of comorbidity in multiple sclerosis","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2020.102685_bib0024","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/1352458510361740","article-title":"Brain MRI lesions characteristic of neuromyelitis optica and positive anti-aquaporin 4-antibody may predict longitudinal extensive myelitis and optic neuritis in Sj\u00f6gren's syndrome","volume":"16","author":"Min","year":"2010","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.msard.2020.102685_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2015.11.031","article-title":"Cognitive and psychiatric comorbidities in neuromyelitis optica","volume":"360","author":"Moore","year":"2016","journal-title":"Journal of the neurological sciences"},{"issue":"5","key":"10.1016\/j.msard.2020.102685_bib0026","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1191\/1352458505ms1207oa","article-title":"Apo E in multiple sclerosis and optic neuritis: the Apo E-o4 allele is associated with progression of multiple sclerosis","volume":"11","author":"Pinholt","year":"2005","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"10.1016\/j.msard.2020.102685_bib0027","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non\u2013organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Archives of neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102685_bib0028","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cbm.190","article-title":"Comorbidity: concepts, claims and choices","volume":"7","author":"Rutter","year":"1997","journal-title":"Criminal Behaviour and Mental Health"},{"issue":"2","key":"10.1016\/j.msard.2020.102685_bib0029","first-page":"81","article-title":"Epidemiology of major depressive disorder in Iran: a systematic review and meta-analysis","volume":"1","author":"Sadeghirad","year":"2010","journal-title":"International journal of preventive medicine"},{"issue":"6","key":"10.1016\/j.msard.2020.102685_bib0030","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1468-1331.2009.02928.x","article-title":"Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients","volume":"17","author":"Sahraian","year":"2010","journal-title":"European journal of neurology"},{"key":"10.1016\/j.msard.2020.102685_bib0031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.msard.2018.07.011","article-title":"Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis","volume":"25","author":"Saroufim","year":"2018","journal-title":"Multiple sclerosis and related disorders"},{"key":"10.1016\/j.msard.2020.102685_bib0032","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review","volume":"27","author":"Shahmohammadi","year":"2018","journal-title":"Multiple sclerosis and related disorders"},{"issue":"6","key":"10.1016\/j.msard.2020.102685_bib0033","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1352458514551780","article-title":"Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis","volume":"21","author":"Simon","year":"2015","journal-title":"Multiple Sclerosis Journal"},{"issue":"4","key":"10.1016\/j.msard.2020.102685_bib0034","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1370\/afm.983","article-title":"Defining comorbidity: implications for understanding health and health services","volume":"7","author":"Valderas","year":"2009","journal-title":"The Annals of Family Medicine"},{"issue":"2","key":"10.1016\/j.msard.2020.102685_bib0035","first-page":"76","article-title":"Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011","volume":"18","author":"Vandad Sharifi","year":"2015","journal-title":"Archives of Iranian medicine"},{"issue":"48","key":"10.1016\/j.msard.2020.102685_bib0036","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013100","article-title":"A multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.msard.2020.102685_bib0037","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102685_bib0038","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"The Lancet Neurology"},{"issue":"10","key":"10.1016\/j.msard.2020.102685_bib0039","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2020.102685_bib0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/neu.2016.49","article-title":"Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica","volume":"29","author":"WLdCJ","year":"2017","journal-title":"Acta neuropsychiatrica"},{"issue":"14","key":"10.1016\/j.msard.2020.102685_bib0041","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000002543","article-title":"Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis","volume":"86","author":"Zhang","year":"2016","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:52:28Z","timestamp":1761900748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820307598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":41,"alternative-id":["S2211034820307598"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102685","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency of comorbidities in Neuromyelitis Optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102685"}}